OBJECTIVES: To estimate the required spatial alignment accuracy for correctly grading 95 % of peripheral zone (PZ) prostate cancers using a system for multiparametric magnetic resonance (MR)-guided ultrasound (US) biopsies. METHODS: PZ prostate tumours were retrospectively annotated on multiparametric MR series using prostatectomy specimens as reference standard. Tumours were grouped based on homogeneous and heterogeneous apparent diffusion coefficient (ADC) values using an automated ADC texture analysis method. The proportion of heterogeneous tumours containing a distinct, high Gleason grade tumour focus yielding low ADC values was determined. Both overall tumour and high-grade focal volumes were calculated. All high-grade target volumes were then used in a simulated US biopsy system with adjustable accuracy to determine the hit rate. RESULTS: An ADC-determined high-grade tumour focus was found in 63 % of the PZ prostate tumours. The focal volumes were significantly smaller than the total tumour volumes (median volume of 0.3 ml and 1.1 ml respectively). To correctly grade 95 % of the aggressive tumour components the target registration error (TRE) should be smaller than 1.9 mm. CONCLUSIONS: To enable finding the high Gleason grade component in 95 % of PZ prostate tumours with MR-guided US biopsies, a technical registration accuracy of 1.9 mm is required. KEY POINTS: • MRI can identify foci of prostatic cancer with reduced apparent diffusion coefficients • Sixty-three per cent of prostatic peripheral zone tumours contain high-grade tumour low ADC foci • The median volume of such foci is 0.3 ml • Biopsy targets are significantly smaller than whole tumour volumes • Simulated registration accuracy is 1.9 mm for correctly grading 95 % of tumours.
OBJECTIVES: To estimate the required spatial alignment accuracy for correctly grading 95 % of peripheral zone (PZ) prostate cancers using a system for multiparametric magnetic resonance (MR)-guided ultrasound (US) biopsies. METHODS: PZ prostate tumours were retrospectively annotated on multiparametric MR series using prostatectomy specimens as reference standard. Tumours were grouped based on homogeneous and heterogeneous apparent diffusion coefficient (ADC) values using an automated ADC texture analysis method. The proportion of heterogeneous tumours containing a distinct, high Gleason grade tumour focus yielding low ADC values was determined. Both overall tumour and high-grade focal volumes were calculated. All high-grade target volumes were then used in a simulated US biopsy system with adjustable accuracy to determine the hit rate. RESULTS: An ADC-determined high-grade tumour focus was found in 63 % of the PZ prostate tumours. The focal volumes were significantly smaller than the total tumour volumes (median volume of 0.3 ml and 1.1 ml respectively). To correctly grade 95 % of the aggressive tumour components the target registration error (TRE) should be smaller than 1.9 mm. CONCLUSIONS: To enable finding the high Gleason grade component in 95 % of PZ prostate tumours with MR-guided US biopsies, a technical registration accuracy of 1.9 mm is required. KEY POINTS: • MRI can identify foci of prostatic cancer with reduced apparent diffusion coefficients • Sixty-three per cent of prostatic peripheral zone tumours contain high-grade tumour low ADC foci • The median volume of such foci is 0.3 ml • Biopsy targets are significantly smaller than whole tumour volumes • Simulated registration accuracy is 1.9 mm for correctly grading 95 % of tumours.
Authors: Thomas Hambrock; Diederik M Somford; Henkjan J Huisman; Inge M van Oort; J Alfred Witjes; Christina A Hulsbergen-van de Kaa; Thomas Scheenen; Jelle O Barentsz Journal: Radiology Date: 2011-05 Impact factor: 11.105
Authors: Anurag K Singh; Jochen Kruecker; Sheng Xu; Neil Glossop; Peter Guion; Karen Ullman; Peter L Choyke; Bradford J Wood Journal: BJU Int Date: 2007-12-05 Impact factor: 5.588
Authors: N M deSouza; S F Riches; N J Vanas; V A Morgan; S A Ashley; C Fisher; G S Payne; C Parker Journal: Clin Radiol Date: 2008-04-18 Impact factor: 2.350
Authors: Christian Herz; Kyle MacNeil; Peter A Behringer; Junichi Tokuda; Alireza Mehrtash; Parvin Mousavi; Ron Kikinis; Fiona M Fennessy; Clare M Tempany; Kemal Tuncali; Andriy Fedorov Journal: IEEE Trans Biomed Eng Date: 2019-05-23 Impact factor: 4.538
Authors: Teodora Telecan; Iulia Andras; Nicolae Crisan; Lorin Giurgiu; Emanuel Darius Căta; Cosmin Caraiani; Andrei Lebovici; Bianca Boca; Zoltan Balint; Laura Diosan; Monica Lupsor-Platon Journal: J Pers Med Date: 2022-06-16
Authors: Ángel Borque-Fernando; Luis Mariano Esteban; Ana Celma; Sarai Roche; Jacques Planas; Lucas Regis; Inés de Torres; Maria Eugenia Semidey; Enrique Trilla; Juan Morote Journal: World J Urol Date: 2019-09-10 Impact factor: 4.226
Authors: A El-Shater Bosaily; M Valerio; Y Hu; A Freeman; C Jameson; L Brown; R Kaplan; R G Hindley; D Barratt; M Emberton; H U Ahmed Journal: Prostate Cancer Prostatic Dis Date: 2016-07-12 Impact factor: 5.554
Authors: Nooshin Ghavami; Yipeng Hu; Eli Gibson; Ester Bonmati; Mark Emberton; Caroline M Moore; Dean C Barratt Journal: Med Image Anal Date: 2019-09-11 Impact factor: 8.545
Authors: Wendy J M van de Ven; Wulphert Venderink; J P Michiel Sedelaar; Jeroen Veltman; Jelle O Barentsz; Jurgen J Fütterer; Erik B Cornel; Henkjan J Huisman Journal: Int Urol Nephrol Date: 2016-04-11 Impact factor: 2.370